Repeated catheter ablation of atrial fibrillation: How to predict outcome?

Circulation Journal

Volumn 77, Issue 9, 2013, Pages 2271-2279

  Wójcik, Maciej ^a,b   Berkowitsch, Alexander ^a   Greiss, Harald ^a   Zaltsberg, Sergey ^a   Pajitnev, Dimitri ^a   Deubner, Nicolas ^a   Hamm, Christian W ^a   Pitschner, Heinz F ^a   Kuniss, Malte ^a   Neumann, Thomas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Atrial fibrillation; CHA2DS2 VASc; CHADS2; Predictors of outcome; Repeated catheter ablation

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER; CATHETER ABLATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HEART TAMPONADE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PULMONARY VEIN; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SCORING SYSTEM; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84882801090     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0308     Document Type: Article

References (50)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagu-lation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370- 2375.
2. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 429S-456S.
3. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fbrillation: A systematic review. Am J Med 2006; 119: 448. 1-19.
4. AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fbrillation: An affrm substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003; 42: 20-29.
5. Kumagai K. Catheter ablation of atrial fibrillation: State of the art. Circ J 2011; 75: 2305-2311.
6. Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM, et al. Long-term outcome of atrial fbrillation ablation: Impact and predictors of very late recurrence. J Cardiovasc Electro-physiol 2010; 21: 1071-1078.
7. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, effcacy, and safety of catheter ablation for human atrial fbrillation. Circulation 2005; 111: 1100-1105.
8. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, effcacy, and safety of catheter ablation for human atrial fbrillation. Circ Arrhythm Electro-physiol 2010; 3: 32-38.
9. Kobza R, Hindricks G, Tanner H, Schirdewahn P, Dorszewski A, Piorkowski C, et al. Late recurrent arrhythmias after ablation of atrial fbrillation: Incidence, mechanisms, and treatment. Heart Rhythm 2004; 1: 676-683.
10. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, defnitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
11. Berkowitsch A, Neumann T, Kuniss M, Janin S, Wojcik M, Zaltsberg S, et al. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: Who is a re-sponder? Pacing Clin Electrophysiol 2010; 33: 1101-1111.
12. Naccarelli GV, Panaccio MP, Cummins G, Tu N. CHADS2 and CHADS2-VASc risk factors to predict frst cardiovascular hospital-ization among atrial fbrillation/atrial futter patients. Am J Cardiol 2012; 109: 1526-1533.
13. Chao TF, Tsao HM, Lin YJ, Tsai CF, Lin WS, Chang SL, et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fbrillation: Results of 3-year follow-up. Circ Arrhythm Electro-physiol 2012; 5: 514-520.
14. Park JH, Joung B, Son NH, Shim JM, Lee MH, Hwang C, et al. The electroanatomical remodelling of the left atrium is related to CHADS2/ CHA2DS2VASC score and events of stroke in patients with atrial f-brillation. Europace 2011; 13: 1541-1549.
15. Ilic LM, Goldenberg EM. CHADS2 score predicts time interval free of atrial fbrillation in patients with symptomatic paroxysmal atrial fibrillation. Int J Cardiol 2010; 145: 576-577.
16. Berkowitsch A, Kuniss M, Greiss H, Wojcik M, Zaltsberg S, Lehinant S, et al. Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fbrillation after catheter ablation: A long term follow-up. Pacing Clin Electrophysiol 2012; 35: 532-543.
17. Neumann T, Kuniss M, Erkapic D, Zaltsberg S, Berkowitsch A, Pajitnev D, et al. Acute and long-term results of PVI at antrum using a novel high-density mapping catheter without help of 3D electro-anatomic mapping in patients with paroxysmal and chronic atrial fbril-lation. J Interv Card Electrophysiol 2010; 27: 101-108.
18. Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, et al. Pulmonary vein antral isolation for paroxysmal atrial fbrillation: Results from long-term follow-up. J Cardiovasc Electrophysiol 2011; 22: 137-141.
19. Katritsis D, Wood MA, Giazitzoglou E, Shepard RK, Kourlaba G, Ellenbogen KA. Long-term follow-up after radiofrequency catheter ablation for atrial fbrillation. Europace 2008; 10: 419-424.
20. Lin YJ, Tsao HM, Chang SL, Lo LW, Tuan TC, Hu YF, et al. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fbrillation. Am J Cardiol 2010; 105: 495-501.
21. Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fbrillation. Am J Cardiol 2009; 104: 366-372.
22. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fbrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
23. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fbrillation: Lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
24. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fbrillation. Heart 2011; 97: 668-673.
25. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fbrillation and repeat catheter ablation on long-term freedom from atrial fbrillation: Results from a multicenter study. Heart Rhythm 2009; 6: 1403-1412.
26. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Ar-rhythm Electrophysiol 2008; 1: 269-275.
27. Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K, et al. Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electro-physiol 2008; 19: 661-667.
28. Hussein AA, Saliba WI, Martin DO, Bhargava M, Sherman M, Magnelli-Reyes C, et al. Natural history and long-term outcomes of ablated atrial fbrillation. Circ Arrhythm Electrophysiol 2011; 4: 271-278.
29. McCready JW, Smedley T, Lambiase PD, Ahsan SY, Segal OR, Rowland E, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fbrillation. Europace 2011; 13: 355-361.
30. Kumagai K, Sakamoto T, Nakamura K, Hayano M, Yamashita E, Oshima S. Pre-procedural prediction of termination of persistent atrial fbrillation by catheter ablation as an indicator of reverse remodeling of the left atrium. Circ J 2013; 77: 1416-1423.
31. Rostock T, Salukhe TV, Steven D, Drewitz I, Hoffmann BA, Bock K, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fbrillation. Heart Rhythm 2011; 8: 1391-1397.
32. Hunter RJ, Ginks M, Ang R, Diab I, Goromonzi FC, Page S, et al. Impact of variant pulmonary vein anatomy and image integration on long-term outcome after catheter ablation for atrial fbrillation. Eu-ropace 2010; 12: 1691-1697.
33. Sato Y, Yoshida K, Ogata K, Inaba T, Tada H, Sekiguchi Y, et al. An increase in right atrial magnetic strength is a novel predictor of recurrence of atrial fbrillation after radiofrequency catheter ablation. Circ J 2012; 76: 1601-1608.
34. Moe GK. On the multiple wavelet hypothesis of atrial fbrillation. Arch Int Pharmacodyn Ther 1962; 140: 183-188.
35. Damiano RJ Jr, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, et al. The long-term outcome of patients with coronary disease and atrial fbrillation undergoing the cox maze procedure. J Thorac Car-diovasc Surg 2003; 126: 2016-2021.
36. Tsao HM, Wu MH, Huang BH, Lee SH, Lee KT, Tai CT, et al. Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fbrillation: Insight from long-term follow-up of three-dimensional magnetic resonance imaging. J Cardiovasc Electro-physiol 2005; 16: 7-12.
37. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, et al. Concomitant chronic kidney disease increases the recurrence of atrial fbrillation after catheter ablation of atrial fbrillation: A midterm follow-up. Heart Rhythm 2011; 8: 335-341.
38. Tokuda M, Yamane T, Matsuo S, Ito K, Narui R, Hioki M, et al. Relationship between renal function and the risk of recurrent atrial fbril-lation following catheter ablation. Heart 2011; 97: 137-142.
39. Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fbrillation. Circ J 2011; 75: 2326-2332.
40. Tuininga YS, Wiesfeld AC, van Veldhuisen DJ, van Gelder IC, Crijns HJ. Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction. J Card Fail 2000; 6: 77-79.
41. Botto GL, Luzi M, Sagone A. Atrial fbrillation: The remodelling phenomenon. Eur Heart J Suppl 2003; 5(Suppl H): 1-7.
42. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, Braunwald E, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 2003; 107: 2577- 2582.
43. Wojcik M, Janin S, Kuniss M, Berkowitsch A, Erkapic D, Zaltsberg S, et al. Limitations of biomarkers serum levels during pulmonary vein isolation. Rev Esp Cardiol 2011; 64: 127-132.
44. Wojcik M, Kuniss M, Berkowitsch A, Zaltsberg S, Janin S, Wysokinski A, et al. Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation. Kardiol Pol 2012; 70: 549-554.
45. D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, et al. Which are the most reliable predictors of recurrence of atrial fbrillation after transcatheter ablation?: A meta-anal-ysis. Int J Cardiol 2012 May 22, doi:10.1016/j.ijcard.2012.05.008 [Epub ahead of print].
46. Kim YH. Catheter ablation of longstanding persistent atrial fbrilla-tion: Are we on the right path? Circ J 2012; 76: 1299-1306.
47. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fbrillation recurrence after radiofrequency catheter ablation: A systematic review. J Cardiovasc Electrophysiol 2010; 21: 1208 -1216.
48. Singer JD, Willett JB. Modeling change using covariance structure analysis. Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press, 2003.
49. Calvo N, Nadal M, Berruezo A, Andreu D, Arbelo E, Tolosana JM, et al. Improved outcomes and complications of atrial fbrillation catheter ablation over time: Learning curve, techniques, and methodology. Rev Esp Cardiol 2012; 65: 131-138 (English edn).
50. Lickfett L, Remerie S, Mittmann-Braun E, Nickenig G. Outcome of atrial fbrillation ablation: Assessment of success. Minerva Cardio-angiol 2008; 56: 635-641.